financetom
Business
financetom
/
Business
/
BRIEF-N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Oct 23, 2025 5:42 AM

Oct 23 (Reuters) - N2OFF Inc ( NITO ):

* N2OFF ANNOUNCES CLOSING OF MERGER WITH DRUG DISCOVERY

COMPANY

TARGETING RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL

CELL LUNG CANCER

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved